Outcomes of sequential third-line therapies in patients with refractory overactive bladder.

Po-Ming ChowTyler TrumpHoward B Goldman

Published in: International journal of urology : official journal of the Japanese Urological Association (2024)

BoNTA or SNM remains a viable option for refractory OAB after patients fail from one another. Spinal pathology is associated with a poorer response of post-SNM BoNTA.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
type diabetes
metabolic syndrome
patient reported outcomes
adipose tissue
spinal cord injury
insulin resistance